Highlights of prescribing information: OZEMPIC (semaglutide) injection, for subcutaneous use
Weight regain after stopping semaglutide is possible and common , especially if old habits return
For musculoskeletal use, it is commonly considered for tendon irritation, ligament sprains, muscle strains, fascia-related pain, overuse injuries, and joint-adjacent soft-tissue pain
This tripeptide, that exists in the reduced or active form (GSH) and oxidized variant (GSH), is the main antioxidant of the body
In clinical trials, gastrointestinal adverse events were reported by a significant proportion of patients, though most were mild to moderate in severity and transient in nature